InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Hygromycin B Gold | Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals q... | 2021 | PLoS One | Matsuo S. et al | DOI: 10.1371/journal.pone.0247595 |
| Human TLR7 Reporter HEK293 Cells (NF-κB) | Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances anti... | 2021 | Nat Commun. | Bahmani B. et al. | DOI: 10.1038/s41467-021-22311-z |
| HEK-Blue™ Detection | Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances anti... | 2021 | Nat Commun. | Bahmani B. et al. | DOI: 10.1038/s41467-021-22311-z |
| Human TLR8 Reporter HEK293 Cells (NF-κB) | Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances anti... | 2021 | Nat Commun. | Bahmani B. et al. | DOI: 10.1038/s41467-021-22311-z |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Newly Isolated Animal Pathogen Corynebacterium silvaticum Is Cytotoxic to Hum... | 2021 | Int J Mol Sci. | Möller J. et al. | DOI: 10.3390/ijms22073549 |
| Human TLR9 Reporter HEK293 Cells (NF-κB) | Newly Isolated Animal Pathogen Corynebacterium silvaticum Is Cytotoxic to Hum... | 2021 | Int J Mol Sci. | Möller J. et al. | DOI: 10.3390/ijms22073549 |
| Primocin® | The role of altered glycosylation in human nucleus pulposus cells in inflamma... | 2021 | Eur Cell Mater | Joyce K. et al. | DOI: 10.22203/eCM.v041a26 |
| HEK-Blue™ Detection | Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melan... | 2021 | Cancers (Basel). | Capitao M. et al. | DOI: 10.3390/cancers13061256 |
| MPLA Synthetic | Differential response induced by LPS and MPLA in immunocompetent and septic i... | 2021 | Clin Immunol | Albert Vega C. et al. | DOI: 10.1016/j.clim.2021.108714 |
| TLR 4 | Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide ... | 2021 | Front Immunol. | Heine H. et al. | DOI: 10.3389/fimmu.2021.631797 |
| TLR4 agonist preparation - MPLA-SM | Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide ... | 2021 | Front Immunol. | Heine H. et al. | DOI: 10.3389/fimmu.2021.631797 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide ... | 2021 | Front Immunol. | Heine H. et al. | DOI: 10.3389/fimmu.2021.631797 |
| QUANTI-Blue™ | Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide ... | 2021 | Front Immunol. | Heine H. et al. | DOI: 10.3389/fimmu.2021.631797 |
| HEK-Blue™ Selection | Palmitoylethanolamide Modulation of Microglia Activation: Characterization of... | 2021 | Int J Mol Sci. | D'Aloia A. et al. | DOI: 10.3390/ijms22063054 |
| pCpGfree-promoter | Genetic and epigenetic factors fine-tune TGFB1 expression within the osteoart... | 2021 | Arthritis Rheumatol. | Rice S.J. et al. | DOI: 10.1002/art.41736 |
| ChemiComp GT115 | Genetic and epigenetic factors fine-tune TGFB1 expression within the osteoart... | 2021 | Arthritis Rheumatol. | Rice S.J. et al. | DOI: 10.1002/art.41736 |
| pCpGfree-promoter | Genetic and epigenetic interplay regulates COLGALT2, contributing to osteoart... | 2021 | Arthritis Rheumatol. | Kehayova Y.S. et al. | DOI: 10.1002/art.41738 |
| LPS-EB VacciGrade™ | Hyaluronan is a natural and effective immunological adjuvant for protein-base... | 2021 | Cell Mol Immunol. | Pietà A.D. et al. | DOI: 10.1038/s41423-021-00667-y |
| Quil-A® adjuvant | Hyaluronan is a natural and effective immunological adjuvant for protein-base... | 2021 | Cell Mol Immunol. | Pietà A.D. et al. | DOI: 10.1038/s41423-021-00667-y |
| AddaVax™ | Hyaluronan is a natural and effective immunological adjuvant for protein-base... | 2021 | Cell Mol Immunol. | Pietà A.D. et al. | DOI: 10.1038/s41423-021-00667-y |